OMERS ADMINISTRATION Corp Takes Position in The Cooper Companies, Inc. $COO

OMERS ADMINISTRATION Corp acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 10,372 shares of the medical device company’s stock, valued at approximately $744,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after buying an additional 7,363 shares during the last quarter. First Trust Advisors LP raised its position in shares of Cooper Companies by 115.8% during the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after acquiring an additional 73,165 shares in the last quarter. Cresset Asset Management LLC purchased a new stake in Cooper Companies during the second quarter worth approximately $291,000. Cerity Partners LLC lifted its stake in Cooper Companies by 4.4% during the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its holdings in Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 973 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Down 2.4%

COO opened at $70.96 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83. The business’s 50 day moving average is $72.46 and its two-hundred day moving average is $70.88. The firm has a market cap of $13.84 billion, a price-to-earnings ratio of 60.14, a price-to-earnings-growth ratio of 1.90 and a beta of 0.83.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the firm earned $0.96 earnings per share. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analyst Ratings Changes

COO has been the subject of several recent analyst reports. Mizuho set a $85.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a research report on Wednesday, May 27th. Citigroup reiterated a “neutral” rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. Stifel Nicolaus reduced their price target on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $81.64.

Get Our Latest Stock Report on Cooper Companies

Cooper Companies Company Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Featured Stories

• Five stocks we like better than Cooper Companies
• Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
• SEC Probe Puts Wall Street Leverage Risk Back in Focus
• A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
• Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).